Clinical Trials Directory

Trials / Unknown

UnknownNCT06187168

Risk Factors of Post-ERCP Sepsis

Intra-operative Hypotension and Sepsis After Endoscopic Retrograde Cholangiopancreatography: A Prospective Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

For the treatment of numerous biliary and pancreatic problems, the procedure known as endoscopic retrograde cholangiopancreatography (ERCP) is regarded as a crucial therapeutic intervention. However, ERCP is known to be connected to a variety of issues, including post-ERCP sepsis. This study's goal is to investigate the relationship between unexplained hypotension during or just after surgery and the emergence of sepsis after ERCP.

Detailed description

At the Gastrointestinal Surgery Centre, Mansura University, Egypt, a cohort study will be conducted on a sample of 50 adult (18+) patients who undergoing ERCP. Hypotension that occurred during surgery or shortly after will be classified as exposure when it cannot be linked to a particular cause. In this study, post-ERCP sepsis will be the major outcome measure, while other ERCP-related sequelae will be the supplementary outcome measures. Discussion: The findings of this study will significantly advance our understanding of the potential link between intraoperative hypotension and the development of post-ERCP sepsis. This study's goal is to increase knowledge of the challenges presented by ERCP, which will aid in the creation of patient treatment methods that are more effective.

Conditions

Interventions

TypeNameDescription
PROCEDUREexposure to hypotension during the Endoscopic Retrograde Cholangiopancreatography (ERCP) for obstructive jundice.This is not an intended intervention in the study. This cohort study will study the exposure to intraoperative hypotension and the occurrence of sepsis after the ERCP procedures.

Timeline

Start date
2023-12-23
Primary completion
2024-03-01
Completion
2024-04-01
First posted
2024-01-02
Last updated
2024-01-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06187168. Inclusion in this directory is not an endorsement.